Insider Shareholders with Direct Ownership of 4 D Molecular Therapeutics, Inc. (FDMT)
This section provides a comprehensive overview of the insiders with direct ownership of 4 D Molecular Therapeutics, Inc. (FDMT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
4D Molecular Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
David Kirn
Chief Executive Officer |
12,930 | 953,777 | 1,059,153 $22.2 Million | 15 |
Jun 24, 2024
Reduced 1.21%
|
|
David Schaffer
Director |
0 | 98,785 | 901,215 $18.9 Million | 7 |
Oct 22, 2021
Reduced 0.21%
|
|
August J Moretti
Chief Financial Officer |
7,000 | 0 | 11,045 $231,834 | 3 |
May 15, 2023
Added 21.36%
|
|
Fariborz Kamal
President and COO |
4,347 | 0 | 4,347 $91,243 | 1 |
Dec 15, 2020
Added 50.0%
|
|
Tony Dung Ling Yao
Director |
2,864 | 0 | 2,864 $60,115 | 1 |
Dec 15, 2020
Added 50.0%
|
|
Scott Bizily
Chief Legal Officer |
47,764 | 48,884 | 1,737 $36,459 | 28 |
Jun 17, 2024
Reduced 50.19%
|
|
Robert Young Kim
Chief Medical Officer |
24,000 | 24,552 | 1,043 $21,892 | 2 |
Feb 05, 2024
Reduced 34.61%
|
| 5,000 | 5,000 | 0 $0 | 2 |
Apr 21, 2023
Reduced 100.0%
|
|